About the association
A unifying platform for a fragmented but urgent field.
Congenital heart disease is the most common birth defect in the world. Yet the industry building its future has no shared home. GCHDA is being built to change that.
The gap
The result: innovation never reaches the children it could help.
Existing organizations focus on clinical care, academic research, or patient advocacy. None serve as the primary commercialization and collaboration platform across pediatric cardiology, ACHD, structural heart, imaging, AI, devices, and regenerative therapeutics.
The result: pediatric devices built off-label from adult tools, regulatory pathways navigated alone, small-market economics that scare off capital, and innovation that never reaches the children it could help.
Mission
To accelerate the development, commercialization, accessibility, and global adoption of congenital cardiovascular technologies through collaboration, advocacy, innovation, and industry leadership.
Vision
The leading global ecosystem for congenital cardiovascular innovation — connecting industry, clinicians, researchers, regulators, investors, and patient communities to improve outcomes worldwide.
The model
A hybrid industry association and innovation consortium.
Industry association
Membership, advocacy, policy engagement, educational programming.
Innovation consortium
Multi-center collaboration, shared research, startup acceleration, commercial matchmaking.
Convening platform
Annual summit, innovation showcases, investor forums, regulatory roundtables.